Vertex Pharmaceuticals (VRTX) EBT Margin (2009 - 2026)
Vertex Pharmaceuticals' quarterly EBT Margin came in at 41.95% in Q1 2026, up 1558.0% year-on-year from 2.53% in Q1 2025, and up 0.53% quarter-over-quarter from 41.72% in Q4 2025.
Vertex Pharmaceuticals has reported EBT Margin for 18 years, with the latest figure at 41.95% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 1558.0% year-over-year to 41.95%; the trailing twelve-month figure through Mar 2026 stood at 42.28% (up 4498.0% YoY), and the FY2025 full-year result was 38.69%, up 3643.0% from the prior year.
- EBT Margin for Q1 2026 stood at 41.95%, up from 41.72% in the prior quarter.
- The five-year high for EBT Margin was 50.4% in Q3 2022, with the low at 128.18% in Q2 2024.
- Average EBT Margin over 5 years is 33.21%, with a median of 44.16% recorded in 2024.
- Year-over-year, EBT Margin plunged 17477 bps in 2024 and jumped 17146 bps in 2025.
- Tracing VRTX's EBT Margin over 5 years: stood at 46.76% in 2022, then declined by 3 bps to 45.58% in 2023, then fell by 14 bps to 39.03% in 2024, then increased by 7 bps to 41.72% in 2025, then climbed by 1 bps to 41.95% in 2026.
- The last three EBT Margin figures came in at 41.95% (Q1 2026), 41.72% (Q4 2025), and 42.22% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.95% |
| Dec 31, 2025 | 41.72% |
| Sep 30, 2025 | 42.22% |
| Jun 30, 2025 | 43.28% |
| Mar 31, 2025 | 26.37% |
| Dec 31, 2024 | 39.03% |
| Sep 30, 2024 | 44.16% |
| Jun 30, 2024 | -128.18% |
| Mar 31, 2024 | 47.54% |
| Dec 31, 2023 | 45.58% |
| Sep 30, 2023 | 47.48% |
| Jun 30, 2023 | 46.59% |
| Mar 31, 2023 | 37.54% |
| Dec 31, 2022 | 46.76% |
| Sep 30, 2022 | 50.40% |
| Jun 30, 2022 | 46.64% |
| Mar 31, 2022 | 45.52% |
| Dec 31, 2021 | 42.02% |
| Sep 30, 2021 | 54.57% |
| Jun 30, 2021 | -2.46% |
| Mar 31, 2021 | 47.61% |
| Dec 31, 2020 | 54.59% |
| Sep 30, 2020 | 48.49% |
| Jun 30, 2020 | 54.10% |
| Mar 31, 2020 | 43.40% |
| Dec 31, 2019 | 434.50% |
| Sep 30, 2019 | 7.44% |
| Jun 30, 2019 | 34.75% |
| Mar 31, 2019 | 37.30% |
| Dec 31, 2018 | 3.73% |
| Sep 30, 2018 | 17.40% |
| Jun 30, 2018 | 28.80% |
| Mar 31, 2018 | 33.50% |
| Dec 31, 2017 | 17.26% |
| Sep 30, 2017 | -72.15% |
| Jun 30, 2017 | 6.53% |
| Mar 31, 2017 | 35.47% |
| Dec 31, 2016 | 4.43% |
| Sep 30, 2016 | -9.53% |
| Jun 30, 2016 | -4.23% |
| Mar 31, 2016 | -7.69% |
| Dec 31, 2015 | -18.71% |
| Sep 30, 2015 | -30.57% |
| Jun 30, 2015 | -114.92% |
| Mar 31, 2015 | -151.60% |
| Dec 31, 2014 | -123.55% |
| Sep 30, 2014 | -121.50% |
| Jun 30, 2014 | -129.49% |
| Mar 31, 2014 | -195.28% |
| Dec 31, 2013 | -15.19% |
| Sep 30, 2013 | -53.63% |
| Jun 30, 2013 | -21.11% |
| Mar 31, 2013 | -132.10% |
| Dec 31, 2012 | -24.18% |
| Sep 30, 2012 | -1.52% |
| Jun 30, 2012 | -3.44% |
| Mar 31, 2012 | 23.42% |
| Dec 31, 2011 | 37.42% |
| Sep 30, 2011 | 47.81% |
| Mar 31, 2011 | -239.06% |
| Dec 31, 2010 | -275.31% |
| Sep 30, 2010 | -878.16% |
| Jun 30, 2010 | -632.49% |
| Mar 31, 2010 | -730.22% |
| Dec 31, 2009 | -445.44% |
| Sep 30, 2009 | -599.29% |
| Jun 30, 2009 | -834.05% |
| Mar 31, 2009 | -678.39% |